SeaSpine Holdings Corporation Gross Profit | SPNE

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:

Raw materials and supplies

Wages of production personnel

Depreciation of equipment

Transportation and warehousing costs (if directly related to production)

Importance for business:

Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales.
Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit.
Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry.
Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.

Reasons for a decline in gross profit:

Increase in raw material and supply costs
Rising production expenses
Price reductions due to competition
Decrease in sales volume
Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit SeaSpine Holdings Corporation

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
115 M	97.5 M	28.1 M	23 M	21.5 M	19.1 M	72.1 M	82 M	91.1 M	92.7 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
115 M	19.1 M	64.2 M

Quarterly Gross Profit SeaSpine Holdings Corporation

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	40.5 M	37.2 M	30.3 M	-	28.2 M	30 M	26.6 M	29.1 M	29.1 M	16.9 M	22.3 M	28.1 M	25.5 M	25 M	22.6 M	23 M	21.6 M	21.8 M	21 M	21.5 M	19.6 M	20.2 M	18.7 M	19.1 M	17.9 M	19.3 M	17.1 M	18.1 M	15.3 M	19 M	19.7 M	20.5 M	19.3 M	20.6 M	21.6 M	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
40.5 M	15.3 M	23.1 M

Gross Profit of other stocks in the Medical devices industry

Issuer	Gross Profit	Price	% 24h	Market Cap	Country
Nano-X Imaging Ltd. NNOX	-12.8 M	$ 0.64	1.15 %	$ 41.5 M	Israel
InspireMD NSPR	2.65 M	$ 0.58	1.64 %	$ 37.3 M	Israel
Orthofix Medical OFIX	566 M	$ 9.5	4.51 %	$ 376 M	Curacao
Outset Medical OM	46.8 M	$ 4.1	3.54 %	$ 62.4 K	USA
PAVmed PAVM	-85 K	$ 2.66	4.36 %	$ 1.78 M	USA
Penumbra PEN	942 M	$ 317.11	0.07 %	$ 12.3 B	USA
Insulet Corporation PODD	1.94 B	$ 135.62	2.98 %	$ 9.54 B	USA
Profound Medical Corp. PROF	11.4 M	$ 6.03	3.25 %	$ 182 M	Canada
Quanterix Corporation QTRX	65 M	$ 3.81	4.67 %	$ 162 M	USA
AVITA Medical RCEL	58.8 M	$ 13.25	4.17 %	$ 369 M	Australia
Sintx Technologies SINT	461 K	$ 2.18	1.05 %	$ 6.05 M	USA
Smith & Nephew plc SNN	4.19 B	$ 26.92	1.87 %	$ 23.3 B	Britain
Sensus Healthcare SRTS	11.9 M	$ 2.92	0.34 %	$ 47.7 M	USA
Stryker Corporation SYK	4.63 B	$ 285.22	3.54 %	$ 109 B	USA
Tactile Systems Technology TCMD	250 M	$ 22.47	1.67 %	$ 514 M	USA
TELA Bio TELA	54.3 M	$ 1.14	0.88 %	$ 53.5 M	USA
TransMedics Group TMDX	363 M	$ 82.99	4.0 %	$ 2.82 B	USA
Tandem Diabetes Care TNDM	167 M	$ 16.52	0.12 %	$ 1.12 B	USA
Viemed Healthcare VMD	155 M	$ 9.24	1.2 %	$ 359 M	USA
Varex Imaging Corporation VREX	290 M	$ 18.45	0.14 %	$ 764 M	USA
Vivos Therapeutics VVOS	10.5 M	$ 0.15	1.52 %	$ 1.54 M	USA
Beyond Air XAIR	252 K	$ 2.84	0.71 %	$ 23.6 B	USA
Xtant Medical Holdings XTNT	84.3 M	$ 0.33	0.09 %	$ 46 M	USA
Zimmer Biomet Holdings ZBH	5.73 B	$ 91.57	3.72 %	$ 18.1 B	USA
Nemaura Medical NMRD	-1.48 M	-	-17.8 %	$ 2.74 M	Britain
Neovasc NVCN	1.99 M	-	-	$ 111 M	Canada
Sientra SIEN	3.23 M	-	-16.59 %	$ 10.3 M	USA
Silk Road Medical, Inc SILK	127 M	-	-	$ 1.07 B	USA
Surgalign Holdings SRGA	40.3 M	-	-32.98 %	$ 1.68 M	USA
ShockWave Medical SWAV	635 M	-	-	$ 12.3 B	USA
Natus Medical Incorporated NTUS	274 M	-	1.94 %	$ 1.05 B	USA
Cardiovascular Systems CSII	173 M	-	0.15 %	$ 844 M	USA
Inari Medical NARI	435 M	-	-	$ 4.23 B	USA
Invacare Corporation IVC	48.3 M	-	-	$ 24.7 M	USA
NuVasive NUVA	865 M	-	-	$ 2.07 B	USA
Axonics Modulation Technologies AXNX	275 M	-	-	$ 3.31 B	USA
ThermoGenesis Holdings THMO	1.93 M	-	-25.84 %	$ 171 K	USA
Talis Biomedical Corporation TLIS	10.9 M	-	3.55 %	$ 7.96 M	USA
Viveve Medical VIVE	620 K	-	-15.35 %	$ 1.71 M	USA
ViewRay VRAY	10 M	-	1.54 %	$ 468 M	USA
SmileDirectClub SDC	328 M	-	-53.45 %	$ 9.71 M	USA
Acutus Medical AFIB	1.01 M	-	-26.83 %	$ 2.62 M	USA
BIOLASE BIOL	16.7 M	-	-13.19 %	$ 166 K	USA
Vapotherm VAPO	28.3 M	-	6.72 %	$ 34 M	USA
Nevro Corp. NVRO	270 M	-	-	$ 217 M	USA
Abiomed ABMD	690 M	-	-	$ 17.2 B	USA
Allied Healthcare Products AHPI	443 K	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	42.4 M	-	-	$ 475 M	USA